Výsledky vyhledávání - "Peter Moosmann"

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study

Autor: Sandro Anchisi, Vera Bühler, Daniel Betticher, Stefanie Pederiva, Roger von Moos, Regina Woelky, Miklos Pless, Marco Dressler, Sacha I. Rothschild, Peter Moosmann, Reinhard Zenhäusern, R. A. Popescu, Markus Borner, Daniel Rauch, Claudia Papet, Antonello Calderoni

Publikováno v: Rothschild, Sacha I; Betticher, Daniel; Zenhäusern, Reinhard; Anchisi, Sandro; von Moos, Roger; Pless, Miklos; Moosmann, Peter; Popescu, Razvan A; Calderoni, Antonello; Dressler, Marco; Rauch, Daniel; Pederiva, Stefanie; Woelky, Regina; Papet, Claudia; Bühler, Vera; Borner, Markus (2019). Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study. Cancer chemotherapy and pharmacology, 84(4), pp. 881-889. Springer 10.1007/s00280-019-03927-x
Cancer Chemotherapy and Pharmacology

PURPOSE The study aimed to investigate strategies to prevent and treat cetuximab-induced skin reactions and their perceived effectiveness in patients with metastatic colorectal cancer (mCRC) and recurrent/metastatic squamous cell cancer of the head a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ebb5f531dd173e90b577ae1e4b90e6
https://doi.org/10.1007/s00280-019-03927-x

Zobrazit plný text záznamu

Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article

Autor: Alexander Siebenhüner, Daniel Helbling, Christoforos Astaras, Petr Szturz, Stefanie Pederiva, Peter Moosmann, Sara De Dosso, Markus Borner, Philippe Von Burg, Thomas Winder

Publikováno v: Oncology research and treatment. 44(9)

Background: Gastric cancer is a leading cause of cancer-related deaths worldwide. Several treatment possibilities have been investigated, but only a few show clinically meaningful results. Summary: Systemic treatment options for advanced gastric canc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969f72d4feb6b5a835b77b8f2f785fcc
https://pubmed.ncbi.nlm.nih.gov/34350899

Zobrazit plný text záznamu

Plný text ve formátu HTML

Alpha Complementation of LacZ in Mammalian Cells

Autor: Sandro Rusconi, Peter Moosmann

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95bf9f70b8da1ca0d4975c579f236949
http://doc.rero.ch/record/290853/files/24-6-1171.pdf

Zobrazit plný text záznamu

Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes

Autor: Valeria Perrina, Matthias S. Matter, Serenella Eppenberger-Castori, Luca Quagliata, Dieter Köberle, Wolfram Jochum, Peter Moosmann, Rainer Grobholz, Mariacarla Andreozzi, Frank Serge Lehmann, Luigi Terracciano, Salvatore Piscuoglio, Daniel Horber, Luigi Tornillo, Katharina Burmeister, Charlotte K.Y. Ng

Publikováno v: PLoS ONE, Vol 12, Iss 4, p e0175563 (2017)
PLoS ONE

VEGFA is an angiogenic factor secreted by tumors, in particular those with VEGFA amplification, as well as by macrophages and lymphocytes in the tumor microenvironment. Here we sought to define the presence of M1/M2 macrophages, PD-1-positive lymphoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc876a2586e411cc8cc9ac4b0f976b1
https://edoc.unibas.ch/68140/

Zobrazit plný text záznamu

Autor: Stefanie Kreissl, Peter Moosmann, Teresa Halbsguth, Andreas Engert, Indra Thielen, Julia Meissner, Hans-Henning Flechtner, Michael Fuchs, Corinne Brillant, Karolin Behringer, Oluwatoyin Shonukan, Volker Diehl, Helen Goergen, Horst Müller, Peter Borchmann, Jens Ulrich Rueffer, Richard Greil

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(36)

Purpose Cancer-related fatigue occurs frequently in patients with Hodgkin lymphoma (HL) and has a major impact on their quality of life. We hypothesized that severe fatigue (sFA) might have an impact on patients’ treatment outcome and social reinte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a087f035748d0f9fb54268ac0d67c59
https://pubmed.ncbi.nlm.nih.gov/27998235

Zobrazit plný text záznamu

Physical activity program in patients with metastatic colorectal cancer who receive palliative first-line chemotherapy: A randomized controlled phase III trial—(ACTIVE-2 SAKK 41/14)

Autor: Catherine Berset, Barbara Handschin, Bernhard C. Pestalozzi, Christine Biaggi Rudolf, Karin Ribi, Stephanie Rondeau, Josef Thaler, Pierre Oliver Bohanes, Marc Kueng, Peter Moosmann, Evelyn Rickenbacher, Ralph Winterhalder, Daniel Horber, Daniel Helbling, Jean-Marc Luthi, Viviane Hess, Stefanie Pederiva

Publikováno v: Journal of Clinical Oncology. 36:TPS3621-TPS3621

TPS3621Background: Exercise has become a main focus of basic and clinical research worldwide during the current pandemic of physical inactivity. A clear link between inactivity and cancer incidence...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b04f58d649d01fdc7663194d0120d47
https://doi.org/10.1200/jco.2018.36.15_suppl.tps3621

Zobrazit plný text záznamu

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Publikováno v: Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollár, Attila; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V and Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of oncology, 26(4), pp. 709-714. Oxford University Press 10.1093/annonc/mdv011
Annals of Oncology, Vol. 26, No 4 (2015) pp. 709-14

In this trial, stopping bevacizumab after completion of induction chemotherapy was associated with a shorter time to progression, but no statistically significant difference in overall survival compared with the bevacizumab continuation strategy. Non

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa47d1f07a0d51e80e0b758ebebd0839
https://boris.unibe.ch/77225/1/709.full.pdf

Zobrazit plný text záznamu

Comparison of Carotid Arterial Resistive Indices With Intima-Media Thickness as Sonographic Markers of Atherosclerosis

Autor: Hans Peter Schmid, Beat Frauchiger, Christian Roedel, Peter Moosmann, Daniel Staub

Publikováno v: Stroke. 32:836-841

Background and Purpose —The intima-media thickness (IMT) of the carotid artery is a (morphological) sonographic parameter that depends on the degree of atherosclerosis. In the renal arteries, the value of the (hemodynamic) resistive index (RI) is c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5b45b193c92ecb406bb846b23b18dcf
https://doi.org/10.1161/01.str.32.4.836

Zobrazit plný text záznamu

A Novel Mitochondrial tRNAPheMutation Inhibiting Anticodon Stem Formation Associated with a Muscle Disease

Autor: Sabina Liechti-Gallati, Peter Moosmann, Stephan Krähenbühl, V. Schneider, Sebastian Brandner, Stephanie Kleinle

Publikováno v: Biochemical and Biophysical Research Communications. 247:112-115

We have identified a novel mitochondrial (mt) DNA mutation in the tRNA(Phe)-gene in a patient with an isolated mitochondrial myopathy. This T to C transition at position 618 disrupts a strictly conserved base pair within the anticodon stem of tRNA(Ph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::996e4a791f0fdc74fa98248df150ac4c
https://doi.org/10.1006/bbrc.1998.8729

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání